Documentos relacionados

1. Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity.
2. We Live in a Digital World: Why We Need to Move out of the Analog Urodynamic Realm.
3. Failures and long-term discontinuations of intradetrusor botulinum toxin injections for neurogenic detrusor overactivity: A new challenge in neurourology.
4. Re: Long-Term Outcomes and Risks Factors for Failure of Intradetrusor Onabotulinumtoxin A Injections for the Treatment of Refractory Neurogenic Detrusor Overactivity.
5. Subjective Outcome after Discontinuation of Botulinum Toxin-A Detrusor Injection for Lower Urinary Tract Disorders: The Majority Suffers!
6. [Isolated continent urinary diversion: An interesting or often regretted indication?]
7. Repeated detrusor injection of botulinum toxin A for neurogenic bladder in children: A long term option?
8. Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
9. Detrusor relaxing agents for neurogenic detrusor overactivity: a systematic review, meta-analysis and network meta-analysis.
10. How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.